Finance

Lists
Why is 688073 down 3.38%?
Dive Deeper
688073:SHA
Bide Pharmatech Co Ltd
CN¥68.12
-3.38%
(-2.38) 1D
Oct 12, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688073...
Open
CN¥71.37
High
CN¥72.00
Low
CN¥67.96
Mkt. cap
6.41B
Avg. vol.
4.97M
Volume
2.64M
Dividend
1.70%
Quarterly dividend
CN¥0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
32.30
52-wk high
CN¥88.88
52-wk low
CN¥43.21
EPS
CN¥2.11
No. of employees
734
Open
CN¥71.37
High
CN¥72.00
Low
CN¥67.96
Mkt. cap
6.41B
Avg. vol.
4.97M
Volume
2.64M
Dividend
1.70%
Quarterly dividend
CN¥0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
32.30
52-wk high
CN¥88.88
52-wk low
CN¥43.21
EPS
CN¥2.11
No. of employees
734
News stories
From web sources and news partners
About Bide Pharmatech Co Ltd
CEO-
Employees734
FoundedApr 27, 2007
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
351.58M
344.70M
323.28M
359.56M
Cost of goods sold
177.36M
229.41M
165.25M
194.66M
Cost of revenue
177.36M
229.41M
165.25M
194.66M
Research and development expenses
20.44M
13.41M
14.99M
13.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69.10M
85.46M
68.86M
71.92M
Operating expense
78.83M
110.37M
81.39M
94.89M
Total operating expenses
256.19M
339.78M
246.63M
289.55M
Operating income
95.39M
4.92M
76.64M
70.01M
Other non operating income
-8.48M
7.57M
-15.67M
13.87M
EBT including unusual items
58.72M
35.86M
61.38M
75.58M
EBT excluding unusual items
92.94M
-1.67M
64.07M
62.13M
Income tax expense
12.39M
3.86M
14.55M
19.10M
Effective tax rate
21.11%
10.75%
23.71%
25.27%
Other operating expenses
-9.25M
11.14M
-3.21M
7.06M
Net income
46.33M
32.01M
46.83M
56.47M
Net profit margin
13.18%
9.29%
14.49%
15.71%
Earnings per share
-
-
-
-
Interest and investment income
4.30M
4.95M
4.19M
4.60M
Interest expense
-1.05M
-1.18M
-1.10M
-1.00M
Net interest expenses
3.25M
3.78M
3.10M
3.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
98.11M
8.47M
80.20M
73.76M
Gain or loss from assets sale
330.57K
-3.90M
-
-4.84M
AI content may include mistakes. Learn more
Google apps